Drug firm Cipla has witnessed three senior-level exits, including that
of the company's Executive Vice-President and CEO for India business
Nikhil Chopra. The other two executives are Nikhil Lalwani, head of
India prescription business, and Kunal Khanna, cluster head of chronic
and emerging business development and portfolio.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-witnesses-3-senior-level-exits-including-india-biz-ceo/articleshow/77351469.cms
No comments:
Post a Comment